Select Page

FW: Product Defect Alert for DBL-METRONIDAZOLE INTRAVENOUS INFUSION 500mg/100mL solution for injection bag

Home Forums Infexion Connexion FW: Product Defect Alert for DBL-METRONIDAZOLE INTRAVENOUS INFUSION 500mg/100mL solution for injection bag

 | Click to Receive Email Notifications of Posts
  • This topic is empty.
Viewing 2 posts - 1 through 2 (of 2 total)
  • Author
    Posts
  • #74554
    Michael Wishart
    Participant

    Author:
    Michael Wishart

    Position:

    Organisation:

    State:
    NSW

    [Posted on behalf of Donna Cameron Moderator]

    Dear Infexion Connexion subscribers,

    I have just seen this product recall that will be of interest to many of you.

    Regards,
    Donna

    Donna Cameron
    Infection Control Consultant
    T +61 (0) 3 8344 3574 (Monday, Wednesday & Friday); +61 (0) 3 9096 5233 (Tuesday & Thursday)
    donna.cameron@unimelb.edu.au
    Microbiological Diagnostic Unit Public Health Laboratory
    The Peter Doherty Institute for Infection and Immunity
    792 Elizabeth Street | Melbourne | Victoria | Australia | 3000
    doherty.edu.au
    [cid:image001.gif@01D3FD7C.B4C863C0]

    From:

    “Australian Society for Antimicrobials” <info@asainc.net.au>

    To:

    “ASA” <info@asainc.net.au>,

    Date:

    06/06/2018 09:12 AM

    Subject:

    Product Defect Alert for DBL??? METRONIDAZOLE INTRAVENOUS INFUSION 500mg/100mL solution for injection bag

    PO Box 8266 Angelo Street
    South Perth 6151 Western Australia
    ABN: 31 081 739 370

    Email: info@asainc.net.au
    Twitter: @AusAntibiotics

    Member Update 05 Jun 2018

    Pfizer Australia has informed ASA of a Product Defect Alert for DBL METRONIDAZOLE INTRAVENOUS INFUSION 500mg/100mL solution for injection bag. See attached letter.

    Please feel free to contact Wayne Lee if you wish to discuss this matter further:

    Wayne Lee
    Associate Medical Director
    Pfizer Essential Health
    Tel: +61 3 8744 5103
    Mob: +61 401 100 383

    Australian Society for Antimicrobials :: https://www.asainc.net.au
    _________________________________________________________________________________

    This email contains confidential information intended only for the person named above and may be subject to legal privilege. If you are not the intended recipient, any disclosure, copying or use of this information is prohibited. The Department provides no guarantee that this communication is free of virus or that it has not been intercepted or interfered with. If you have received this email in error or have any other concerns regarding its transmission, please notify Postmaster@dhhs.vic.gov.au
    _________________________________________________________________________________

    ______________________________________________________________________
    This email and any attachments to it (the “Email”) is confidential and is for the use only of the intended recipient, and may not be duplicated or used by any other party without the express consent of the sender. If you are not the intended recipient of the Email, please notify the sender immediately by return email, delete the Email, and do not copy, print, retransmit, store or act in reliance on the Email. St Vincent’s Health Australia (“SVHA”) does not guarantee that the Email is free from errors, viruses or interference. Emails to and from SVHA or its related entities may be scanned and filtered in locations outside Australia.

    ______________________________________________________________________
    This email and any attachments to it (the “Email”) is confidential and is for the use only of the intended recipient, and may not be duplicated or used by any other party without the express consent of the sender. If you are not the intended recipient of the Email, please notify the sender immediately by return email, delete the Email, and do not copy, print, retransmit, store or act in reliance on the Email. St Vincent’s Health Australia (“SVHA”) does not guarantee that the Email is free from errors, viruses or interference. Emails to and from SVHA or its related entities may be scanned and filtered in locations outside Australia.

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@

    #74556
    Michael Wishart
    Participant

    Author:
    Michael Wishart

    Position:

    Organisation:

    State:
    NSW

    It seems the attachment was omitted. Trying again.

    Michael Wishart, CICP-E
    Infection Control Coordinator

    A 627 Rode Road, Chermside QLD 4032
    P (07) 3326 3068 | F (07) 3607 2226 | E michael.wishart@svha.org.au | W http://www.hsnph.org.au
    [cid:image001.png@01D01926.61F1C2B0] [cid:image004.jpg@01D3FD8B.1757FC40]
    P Please consider the environment before printing this email

    From: ACIPC Infexion Connexion [mailto:AICALIST@AICALIST.ORG.AU] On Behalf Of Michael Wishart
    Sent: Wednesday, 6 June 2018 11:37 AM
    To: AICALIST@AICALIST.ORG.AU
    Subject: [ACIPC_Infexion_Connexion] FW: Product Defect Alert for DBL METRONIDAZOLE INTRAVENOUS INFUSION 500mg/100mL solution for injection bag

    [Posted on behalf of Donna Cameron Moderator]

    Dear Infexion Connexion subscribers,

    I have just seen this product recall that will be of interest to many of you.

    Regards,
    Donna

    Donna Cameron
    Infection Control Consultant
    T +61 (0) 3 8344 3574 (Monday, Wednesday & Friday); +61 (0) 3 9096 5233 (Tuesday & Thursday)
    donna.cameron@unimelb.edu.au
    Microbiological Diagnostic Unit Public Health Laboratory
    The Peter Doherty Institute for Infection and Immunity
    792 Elizabeth Street | Melbourne | Victoria | Australia | 3000
    doherty.edu.au
    [cid:image001.gif@01D3FD7C.B4C863C0]

    From:

    “Australian Society for Antimicrobials” <info@asainc.net.au>

    To:

    “ASA” <info@asainc.net.au>,

    Date:

    06/06/2018 09:12 AM

    Subject:

    Product Defect Alert for DBL??? METRONIDAZOLE INTRAVENOUS INFUSION 500mg/100mL solution for injection bag

    PO Box 8266 Angelo Street
    South Perth 6151 Western Australia
    ABN: 31 081 739 370

    Email: info@asainc.net.au
    Twitter: @AusAntibiotics

    Member Update 05 Jun 2018

    Pfizer Australia has informed ASA of a Product Defect Alert for DBL METRONIDAZOLE INTRAVENOUS INFUSION 500mg/100mL solution for injection bag. See attached letter.

    Please feel free to contact Wayne Lee if you wish to discuss this matter further:

    Wayne Lee
    Associate Medical Director
    Pfizer Essential Health
    Tel: +61 3 8744 5103
    Mob: +61 401 100 383

    Australian Society for Antimicrobials :: https://www.asainc.net.au
    _________________________________________________________________________________

    This email contains confidential information intended only for the person named above and may be subject to legal privilege. If you are not the intended recipient, any disclosure, copying or use of this information is prohibited. The Department provides no guarantee that this communication is free of virus or that it has not been intercepted or interfered with. If you have received this email in error or have any other concerns regarding its transmission, please notify Postmaster@dhhs.vic.gov.au
    _________________________________________________________________________________

    ______________________________________________________________________
    This email and any attachments to it (the “Email”) is confidential and is for the use only of the intended recipient, and may not be duplicated or used by any other party without the express consent of the sender. If you are not the intended recipient of the Email, please notify the sender immediately by return email, delete the Email, and do not copy, print, retransmit, store or act in reliance on the Email. St Vincent’s Health Australia (“SVHA”) does not guarantee that the Email is free from errors, viruses or interference. Emails to and from SVHA or its related entities may be scanned and filtered in locations outside Australia.

    ______________________________________________________________________
    This email and any attachments to it (the “Email”) is confidential and is for the use only of the intended recipient, and may not be duplicated or used by any other party without the express consent of the sender. If you are not the intended recipient of the Email, please notify the sender immediately by return email, delete the Email, and do not copy, print, retransmit, store or act in reliance on the Email. St Vincent’s Health Australia (“SVHA”) does not guarantee that the Email is free from errors, viruses or interference. Emails to and from SVHA or its related entities may be scanned and filtered in locations outside Australia.

    ______________________________________________________________________
    This email and any attachments to it (the “Email”) is confidential and is for the use only of the intended recipient, and may not be duplicated or used by any other party without the express consent of the sender. If you are not the intended recipient of the Email, please notify the sender immediately by return emhttps://clicktime.symantec.com/a/1/Eva1Wjr8W60tkRjJTww6P9XdgcyKXxwts8-UwT1JGjE=?d=ZGFIdlLcRB-hcrnuQelKJCtbDtKTBbu6pIehjApxoCkuIUdAAXDpEMh_Ar18gpCHNoFuyb6MeuG34OPtUmWBP11_gXInJ_xeakCxabTIRjl0XRmzRb1xVo5-IOl8dkBUk434vIgu52JbinhceH3s-hX_eLPBZW1e1bGZAiLXhhBLeP4iXsiLN1M0LXB_Arg5uVf7QGg2v7js2ckEYWchj0_Y4i5CDehLmcy7ERHhBRwU3gXaI_dWzafP-K2t6WUIqUaPt45ChoF03WQR8Tg8sT3HUpOWX_IbaLqrzBPiWorKwGyxzw0Q4X_uaUyLZ-PLDWLb-UV-gDXa_n-oOWiDojOg8RUfP2gPTwfww0isCwcbAEzw46lfcD0GslZqr0MECMZU1xeET0km1bwC30sCjrEYg8quEoEYJhDe0XkxfKX700qLEYP3r2IUpRiIPxzcK9KDzV7X9zxWnzZSsKlX9bNHCINPU9Vyl3ApSNf-YeV1vzsRGTk%3D&u=ail%2C%20delete%20the%20Email%2C%20and%20do%20not copy, print, retransmit, store or act in reliance on the Email. St Vincent’s Health Australia (“SVHA”) does not guarantee that the Email is free from errors, viruses or interference. Emails to and from SVHA or its related entities may be scanned and filtered in locations outside Australia.
    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    ______________________________________________________________________
    This email and any attachments to it (the “Email”) is confidential and is for the use only of the intended recipient, and may not be duplicated or used by any other party without the express consent of the sender. If you are not the intended recipient of the Email, please notify the sender immediately by return email, delete the Email, and do not copy, print, retransmit, store or act in reliance on the Email. St Vincent’s Health Australia (“SVHA”) does not guarantee that the Email is free from errors, viruses or interference. Emails to and from SVHA or its related entities may be scanned and filtered in locations outside Australia.

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without t

Viewing 2 posts - 1 through 2 (of 2 total)
  • The forum ‘Infexion Connexion’ is closed to new topics and replies.